These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 31907692)
1. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity. El-Banna HS; El Khouly RM; Gado SE Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692 [TBL] [Abstract][Full Text] [Related]
2. Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity. Xie HH; Shen H; Zhang L; Cui MY; Xia LP; Lu J Sci Rep; 2018 Feb; 8(1):3462. PubMed ID: 29472590 [TBL] [Abstract][Full Text] [Related]
3. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus. Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P Front Immunol; 2021; 12():663192. PubMed ID: 34054830 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928 [TBL] [Abstract][Full Text] [Related]
5. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H; Ekblom-Kullberg S; Miettinen A Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Interleukin 17 in Egyptian Systemic Lupus Erythematosus Patients as a Biomarker in Disease Activity. Behiry M; Wadie M; Mohamed NA; Farid R; Ramadan H Curr Rheumatol Rev; 2024; 20(5):534-543. PubMed ID: 38299415 [TBL] [Abstract][Full Text] [Related]
7. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156 [TBL] [Abstract][Full Text] [Related]
8. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus. Wu Q; Yang Q; Sun H Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754 [TBL] [Abstract][Full Text] [Related]
9. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients. Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892 [TBL] [Abstract][Full Text] [Related]
10. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus. Wang H; Cao J; Lai X Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients. He D; Liu M; Liu B Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585 [TBL] [Abstract][Full Text] [Related]
12. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE. Tripathy R; Panda AK; Das BK Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568 [TBL] [Abstract][Full Text] [Related]
13. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis. Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080 [TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
15. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401 [TBL] [Abstract][Full Text] [Related]
16. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus. Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T Front Immunol; 2018; 9():1250. PubMed ID: 29930551 [TBL] [Abstract][Full Text] [Related]
18. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study. Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127 [TBL] [Abstract][Full Text] [Related]
19. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic. Nasiri S; Karimifar M; Bonakdar ZS; Salesi M Rheumatol Int; 2010 Nov; 30(12):1605-9. PubMed ID: 19809816 [TBL] [Abstract][Full Text] [Related]
20. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]